BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 25442431)

  • 21. Cardiac application of embryonic stem cells.
    Xiao YF
    Sheng Li Xue Bao; 2003 Oct; 55(5):493-504. PubMed ID: 14566394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.
    Rikhtegar R; Pezeshkian M; Dolati S; Safaie N; Afrasiabi Rad A; Mahdipour M; Nouri M; Jodati AR; Yousefi M
    Biomed Pharmacother; 2019 Jan; 109():304-313. PubMed ID: 30396088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cells for heart cell therapies.
    Jing D; Parikh A; Canty JM; Tzanakakis ES
    Tissue Eng Part B Rev; 2008 Dec; 14(4):393-406. PubMed ID: 18821841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovation in basic science: stem cells and their role in the treatment of paediatric cardiac failure--opportunities and challenges.
    Kaushal S; Jacobs JP; Gossett JG; Steele A; Steele P; Davis CR; Pahl E; Vijayan K; Asante-Korang A; Boucek RJ; Backer CL; Wold LE
    Cardiol Young; 2009 Nov; 19 Suppl 2():74-84. PubMed ID: 19857353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beating heart cells--targeted diagnostics, individual optimization of therapy and tailored cell therapies].
    Kankuri E; Harjula A; Pätilä T; Penttinen K; Aalto-Setälä K
    Duodecim; 2014; 130(19):2001-8. PubMed ID: 25558621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes.
    Cao F; Wagner RA; Wilson KD; Xie X; Fu JD; Drukker M; Lee A; Li RA; Gambhir SS; Weissman IL; Robbins RC; Wu JC
    PLoS One; 2008; 3(10):e3474. PubMed ID: 18941512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes.
    Capi O; Gepstein L
    J Control Release; 2006 Nov; 116(2):211-8. PubMed ID: 17005287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regenerative medicine for the heart: perspectives on stem-cell therapy.
    Cho GS; Fernandez L; Kwon C
    Antioxid Redox Signal; 2014 Nov; 21(14):2018-31. PubMed ID: 25133793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
    Sadahiro T; Yamanaka S; Ieda M
    Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac cell therapies: the next generation.
    Choi YH; Saric T; Nasseri B; Hühn S; Van Linthout S; Hetzer R; Tschöpe C; Stamm C
    Cardiovasc Ther; 2011 Feb; 29(1):2-16. PubMed ID: 20946322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.
    Emmert MY; Wolint P; Wickboldt N; Gemayel G; Weber B; Brokopp CE; Boni A; Falk V; Bosman A; Jaconi ME; Hoerstrup SP
    Biomaterials; 2013 Sep; 34(27):6339-54. PubMed ID: 23727259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac repair and restoration using human embryonic stem cells.
    Bernstein HS
    Regen Med; 2012 Sep; 7(5):697-712. PubMed ID: 22954440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective.
    Poon E; Kong CW; Li RA
    Mol Pharm; 2011 Oct; 8(5):1495-504. PubMed ID: 21879736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.